NOF CORPORATION et al. vs. Nektar Therapeutics et al.
Explore the PTAB proceeding IPR2019-01394 filed by NOF CORPORATION et al. on 2019-07-25. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2019-01394
Filing Date
2019-07-25
Accorded Filing Date
2019-07-25
Institution Decision Date
2020-02-05
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2021-07-30
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
NOF CORPORATION et al.
Represented By
Donovan, Thomaset alPatent Owner / Respondent
Nektar Therapeutics et al.
Represented By
Haug, Edgaret alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34141 | Michael Connor | +1 704-444-1022 |
| 34610 | Guy Gosnell | +1 704-444-1000 |
| 35704 | George Taulbee | +1 704-444-1000 |
| 37505 | Joe Liebeschuetz | +1 650-838-2038 |
| 38114 | Jason Cooper | +1 404--88-1-7000 |
| 38337 | David Teske | +1 404-881-7000 |
| 42365 | Keith Broyles | +1 404-881-7000 |
| 44316 | Susan Sather | +1 650-838-2069 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 7,026,440 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 7,872,072 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,273,833 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,440,816 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,809,453 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,187,569 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2016003204 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2020004841 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 33,761,301 P | US Continuation / Sibling | View Official Patent → |
NOF CORPORATION et al. v. Nektar Therapeutics et al.
NOF CORPORATION et al. v. Nektar Therapeutics et al.
NOF CORPORATION et al. v. Nektar Therapeutics et al.
NOF CORPORATION et al. v. Nektar Therapeutics et al.
NOF CORPORATION et al. v. Nektar Therapeutics et al.